Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia

被引：0
|
作者：
Medeiros, Bruno C. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
ACTA HAEMATOLOGICA | 2014年 / 131卷 / 04期
关键词：
1ST RELAPSE;
D O I：
10.1159/000355134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [21] Continuous drip infusion therapy of low dose cytarabine and etoposide for hypoplastic acute myeloid leukemia
    Yamada, T
    Tsurumi, H
    Sawada, M
    Kasahara, S
    Hara, T
    Fukuno, K
    Kanemura, N
    Goto, H
    Oyama, M
    Moriwaki, H
    BLOOD, 2002, 100 (11) : 261B - 261B
  • [22] Idarubicin, high-dose cytarabine and etoposide for induction of remission in acute myeloid leukemia.
    Singhal, S
    Powles, R
    Treleaven, J
    Horton, C
    Hamblin, M
    Zomas, A
    Prendiville, J
    Saso, R
    Mackay, H
    Milan, S
    Mehta, J
    BLOOD, 1995, 86 (10) : 2039 - 2039
  • [23] A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
    Ocadlikova, Darina
    Iannarone, Clara
    Redavid, Anna Rita
    Cavo, Michele
    Curti, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 20
  • [24] Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.
    Bhatnagar, Bhavana
    Walker, Alison R.
    Mims, Alice S.
    Vasu, Sumithira
    Klisovic, Rebecca B.
    Behbehani, Gregory
    Blachly, James Stewart
    Larkin, Karilyn T. M.
    Long, Meixiao
    Zhao, Qiuhong
    Ranganathan, Parvathi
    Byrd, John C.
    Blum, William G.
    Garzon, Ramiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] MITOXANTRONE, ETOPOSIDE AND CYTARABINE IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA
    BJORKHOLM, M
    BJORNSDOTTIR, J
    STENKE, L
    GRIMFORS, G
    ONCOLOGY, 1990, 47 (02) : 112 - 114
  • [26] Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
    Nakayama, Hideki
    Tomizawa, Daisuke
    Tanaka, Shiro
    Iwamoto, Shotaro
    Shimada, Akira
    Saito, Akiko M.
    Yamashita, Yuka
    Moritake, Hiroshi
    Terui, Kiminori
    Taga, Takashi
    Matsuo, Hidemasa
    Kosaka, Yoshiyuki
    Koh, Katsuyoshi
    Hosoi, Hajime
    Kurosawa, Hidemitsu
    Isoyama, Keiichi
    Horibe, Keizo
    Mizutani, Shuki
    Adachi, Souichi
    PEDIATRICS INTERNATIONAL, 2017, 59 (10) : 1046 - 1052
  • [27] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    O'Hagan Henderson, Samantha
    Frietsch, Jochen J.
    Hilgendorf, Inken
    Hochhaus, Andreas
    Koehne, Claus-Henning
    Casper, Jochen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2599 - 2609
  • [28] A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Tsimberidou, Apostolia Maria
    Keating, Michael J.
    Jabbour, Elias J.
    Ravandi-Kashani, Farhad
    O'Brien, Susan
    Estey, Elihu
    Bekele, Neby
    Plunkett, William K., Jr.
    Kantarjian, Hagop
    Borthakur, Gautam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 395 - 400
  • [29] CONTINUOUS SEQUENTIAL INFUSION OF FLUDARABINE AND CYTARABINE FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA SECONDARY TO MYELODYSPLASTIC SYNDROME
    Ferrara, F.
    Palmieri, S.
    Mele, G.
    Izzo, T.
    Criscuolo, C.
    Pedata, M.
    Riccardi, C.
    Pocali, B.
    Califano, C.
    D'Arco, A. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 118 - 118
  • [30] Increased in vitro cytotoxicity of cytarabine when combined with fludarabine towards childhood acute myeloid leukemia cells
    Kaspers, GJL
    Litvinova, E
    Hubeek, I
    Haarman, EG
    Huismans, DR
    Peters, GJ
    Veerman, AJP
    LEUKEMIA, 2001, 15 (03) : 497 - 497
12345